One little pearl from the Allergan investor presentation is that the company is expecting Rhofade to be approved by the FDA in early 2017. Allergan Plc (AGN) Brenton L. Saunders on Q2 2016 Results – Earnings Call Transcript Aug. 8, 2016 2:03 PM ET About: Allergan plc (AGN) William J. Meury – Chief Commercial Officer […]

More...